Gerald Visit 1: A 53-year-old man with type 2 diabetes

Title:	Gerald Visit 1: A 53-year-old man with type 2 diabetes
Topic:	Ophthalmology
Relevant Terms:	Diabetes, Diabetic Macular Edema, Diabetic Retinopathy, Dyslipidemia, Eye Care, Hypertension, Hypoglycemia, Obesity
Primary Audience:	Physicians and Pharmacists in both primary care and specialty practice; Dieticians; Nurse Practitioners; Nurses; Physician Assistants.
Launch Date:	16-Nov-11
Credits:	0.5 AMA PRA Category 1 Credit™
Expiration Date:	The accreditation for this activity has expired.
Curriculum Name:	Improving the Recognition and Treatment of Diabetic Macular Edema: The Importance of Patient...

Enter this activity!

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

Discuss the indications for therapeutic interventions for diabetic retinal disease
Discuss newer treatment modalities for diabetic macular edema
Describe a communication approach whereby eye-care professionals can engage their patients to insure that they receive timely ophthalmologic interventions for diabetic eye disease
Outline a process that can be initiated in an ophthalmologic or optometric practice whereby patients with diabetic macular edema can be insured of receiving the latest treatments for this condition in a timely manner

Faculty

Jerry Cavallerano, OD
Staff Optometrist and Chief of Telemedicine
Beetham Eye Institute
Joslin Diabetes Center
Boston, MA

Jerry Cavallerano, OD

Dr. Jerry Cavallerano is a staff optometrist, Beetham Eye Institute, Joslin Diabetes Center, and Associate Professor, Department of Ophthalmology, Harvard Medical School. He received his Ph.D. from Fordham University, Bronx, NY and his O.D. from the New England College of Optometry.

Dr. Cavallerano was a clinical co-investigator for the Diabetes Control and Complications Trial, the Early Treatment Diabetic Retinopathy Study, and other clinical trials sponsored by the National Institutes of Health and other funding sources. He has assisted in the design and implementation of single-center trials on behalf of the National Eye Institute sponsored Diabetic Retinopathy Clinical Research Network (DRCR.net) and is a named author on the manuscripts from these studies. He serves both as a certified refractionist and visual acuity examiner for the DRCR.net as well as a certifying DRCR.net examiner for both of these activities.

Dr. Cavallerano served on the American Optometric Association's (AOA) Clinical Care Guidelines Committee, co-authored the AOA's Clinical Care Guideline on Optometric Care of the Patient with Diabetes, and was a co-author of the American Diabetes Association's Clinical Practice Recommendations for Diabetic Retinopathy and the Technical Review to support the Clinical Practice Recommendations. He has authored or co-authored more than 85 articles, reviews, and book chapters, predominantly on diabetic retinopathy and ocular telemedicine, and he has lectured extensively on diabetic eye disease.

Dr. Cavallerano is former Chairman of the Ocular Telehealth Special Interest Group of the American Telemedicine Association and recognized leader in the field of ocular telemedicine, and a co-author of the ATA's Telehealth Practice Recommendations for Diabetic Retinopathy. He serves as Chief, Beetham Eye Institute Center for Ocular Telehealth at the Joslin Diabetes Center.

Dr. Cavallerano has served as editor of the New England Journal of Optometry and on the editorial boards of Diabetes Spectrum and Clinical Diabetes. He is presently on the scientific editorial review board of Review of Optometry and Telemedicine and e-Health and a reviewer for numerous journals.

Paolo S. Silva, MD
Instructor in Ophthalmology
Harvard Medical School
Assistant Chief, Center for Ocular Telehealth
Beetham Eye Institute
Joslin Diabetes Center
Boston, MA

Jennifer K. Sun, MD, MPH
Assistant Professor
Harvard Medical School
Assistant Investigator
Joslin Diabetes Center
Boston, MA

Planning Committee

Richard S. Beaser, MD

Associate Clinical Professor of Medicine

Harvard Medical School

Medical Executive Director

Professional Education

Joslin Diabetes Center

Boston, MA

Julie Brown

Director

Professional Education

Joslin Diabetes Center

Boston, MA

James E. Neighbours, MEd
Associate Director
Education Design
Joslin Diabetes Center
Boston, MA

Eyiuche Okeke, MD
Instructor in Medicine
Harvard Medical School
Outcomes Investigator
Department of Professional Education
Staff Endocrinologist
Joslin Diabetes Center
Boston, MA

Jonathan Scoble

Grants Manager

Professional Education

Joslin Diabetes Center

Boston, MA

Kenneth J. Snow, MD, MBA
Assistant Professor of Clinical Medicine
Harvard Medical School
Director, Medical Programs, Strategic Initiatives
Senior Physician, Adult Diabetes Section
Joslin Diabetes Center
Boston, MA

CME Advisory Committee

Richard S. Beaser, MD

Associate Clinical Professor of Medicine

Harvard Medical School

Medical Executive Director, Professional Education

Joslin Diabetes Center

Boston, MA

Julie A. Brown
Director
Professional Education
Joslin Diabetes Center
Boston, MA

Enrique Caballero, MD
Director, Medical Affairs
Professional Education
Director, Latino Diabetes Initiative
Joslin Diabetes Center
Boston, MA

Jerry Cavallerano, OD, PhD

Optometrist

Beetham Eye Institute

Joslin Diabetes Center

Boston, MA

A. Patrick Egan, MD

Family Practice
Internal Medicine Specialist

Dorchester House Multi-Service Center

Boston, MA

Ann E. Goebel-Fabbri, PhD

Instructor in Psychiatry

Harvard Medical School

Psychologist

Behavioral and Mental Health Unit

Joslin Diabetes Center

Boston, MA

Osama Hamdy, MD, PhD, FACE

Assistant Professor of Medicine

Harvard Medical School

Medical Director, Obesity Clinical Program

Joslin Diabetes Center

Boston, MA

Karen Kuc

Assistant Director

Professional Education

Joslin Diabetes Center

Boston, MA

James Neighbours, MEd

Associate Director
Education Design

Professional Education

Joslin Diabetes Center

Boston, MA

Jonathan Scoble

Grants Manager

Professional Education

Joslin Diabetes Center

Boston, MA

Kenneth J. Snow, MD, MBA

Assistant Professor of Clinical Medicine

Harvard Medical School

Senior Physician, Adult Diabetes Section

Joslin Diabetes Center

Boston, MA

Robert C. Stanton, MD

Associate Professor of Medicine

Harvard Medical SchoolF

Chief of Nephrology

Joslin Diabetes Center

Boston, MA

Howard Wolpert, MD

Assistant Professor of Medicine

Harvard Medical School

Director, Insulin Pump Program

Senior Physician

Joslin Diabetes Center

Boston, MA

DISCLOSURE POLICY STATEMENT

As part of its accreditation with the Accreditation Council for Continuing Medical Education, Joslin Diabetes Center, Boston, must disclose to the audience of a Joslin continuing medical education activity the existence of any relevant financial relationships between Joslin and/or its planning committee members, speakers, and their spouses/partners and commercial entities. Joslin and its planning committee members and speakers must disclose any relationships they and their spouses/partners have or have had in the prior 12 months with proprietary entities producing healthcare goods or services with the exception of nonprofit or government organizations and non–healthcare-related companies, which are exempt.

Financial relationships are those relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fees, honoraria, ownership interests (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds) or other financial benefit in any amount. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.

If a faculty or planning committee member has no information to disclose, this information will also be provided. If a faculty or planning committee member refuses to disclose, he/she will not be able to participate in the planning, management, presentation, or evaluation of any Joslin Diabetes Center CME activity. In addition, faculty have been asked to disclose when a product or device is not labeled for the use under discussion. The opinions and comments expressed in this program are those of the speakers and should not be considered the opinions or comments of the Joslin Diabetes Center.

Faculty

Dr. Jerry Cavallerano has no relevant financial relationships.

Dr. Jennifer Sun is a consultant for Abbott Laboratories and Novartis Pharmaceuticals Corporation; and is a consultant for and receives grant/research support from Genentech, Inc.

Dr. Paolo Silva has no relevant financial relationships.

Planning Committee

Dr. Richard S. Beaser, Medical Executive Director, Professional Education, Joslin Diabetes Center, is a consultant for CeQur LTD.**

Julie A. Brown, Director, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.**

Dr. Okeke, outcomes investigator, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.

Dr. Kenneth J. Snow, Senior Physician, Adult Diabetes Section, Joslin Diabetes Center, has no relevant financial relationships.**

**Also on the CME Advisory Commitee

CME Advisory Committee

Dr. Enrique Caballero, Director, Medical Affairs, Professional Education, Director, Latino Diabetes Initiative, Joslin Diabetes Center, is a consultant and on the speakers bureau and scientific advisory board for Amylin Pharmaceuticals, Inc., AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Company, Daiichi Sankyo, Inc., and Eli Lilly and Company.

Dr. Jerry Cavallerano, Optometrist, Beetham Eye Institute, Joslin Diabetes Center, has no relevant financial relationships.

Dr. A. Patrick Egan, Family Practice, Internal Medicine Specialist, Dorchester House Multi-Service Center, has no relevant financial relationships.

Anne E. Goebel-Fabbri, Psychologist, Behavioral and Mental Health Unit, Joslin Diabetes Center, has no relevant financial relationships.

Dr. Osama Hamdy, Medical Director, Obesity Clinical Program, Joslin Diabetes Center, is on the speakers bureau for Amylin Pharmaceuticals, Inc., Bristol-Myers Squibb Company, Merck & Co., Inc., Novo Nordisk Inc., sanofi-aventis U.S., and Takeda Pharmaceuticals North America, Inc.

Karen J. Kuc, Assistant Director, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.

James Neighbours, Associate Director, Education Design, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.*

Jonathan Scoble, Grants Manager, Professional Education, Joslin Diabetes Center, has no relevant financial relationships.*

Dr. Robert C. Stanton, Chief of Nephrology, Joslin Diabetes Center, has no relevant financial relationships.

Dr. Howard A. Wolpert, Director of the Insulin Pump Program and Senior Physician, Joslin Diabetes Center, is a consultant for Abbott Diabetes Care, Insulet Corporation, Novo Nordisk, Inc., and Becton, Dickinson and Company.

*Also on the planning committee.

ACCREDITATION STATEMENT

The Joslin Diabetes Center, Boston, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION

Joslin Diabetes Center designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

To Obtain CME Credits

Read the learning objectives and faculty disclosures.
Participate in the activity.
Complete the post-test and activity evaluation.
Physicians who successfully complete the post-test and evaluation will receive CME credit.
You must score 65% or higher on the post-test to receive credit for this activity.
All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.

COURSE VIEWING REQUIREMENTS

PC
Internet Explorer (v6 or greater), or Firefox

MAC
Safari

Release Date: November 16, 2011

Expiration Date: November 15, 2012

ACKNOWLEDGEMENT

This activity is sponsored by Joslin Diabetes Center.

This activity is supported by an educational grant from Genentech, Inc.

If you have any questions regarding this activity, send an email to profedweb@joslin.harvard.edu.

Copyright © 2011 by Joslin Diabetes Center, Inc. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Joslin Diabetes Center is prohibited.

Enter this activity!

These activities require registration. Registration time is less than two minutes, and will provide you access to your personal CMECompanion toolset.

If you are already registered, please log in.

(+) What is CMECompanion?